The stock of Imunon Inc (IMNN) has seen a -3.30% decrease in the past week, with a -5.76% drop in the past month, and a 15.04% flourish in the past quarter. The volatility ratio for the week is 5.27%, and the volatility levels for the past 30 days are at 6.37% for IMNN. The simple moving average for the past 20 days is -4.61% for IMNN’s stock, with a -20.30% simple moving average for the past 200 days.
Is It Worth Investing in Imunon Inc (NASDAQ: IMNN) Right Now?
IMNN has 36-month beta value of 1.97. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IMNN is 13.79M, and currently, short sellers hold a 7.80% ratio of that float. The average trading volume of IMNN on February 19, 2025 was 243.42K shares.
IMNN) stock’s latest price update
Imunon Inc (NASDAQ: IMNN) has seen a decline in its stock price by -0.17 in relation to its previous close of 0.86. However, the company has experienced a -3.30% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-19 that Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose
IMNN Trading at -3.23% from the 50-Day Moving Average
After a stumble in the market that brought IMNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.42% of loss for the given period.
Volatility was left at 6.37%, however, over the last 30 days, the volatility rate increased by 5.27%, as shares sank -3.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.03% upper at present.
During the last 5 trading sessions, IMNN fell by -2.91%, which changed the moving average for the period of 200-days by -34.05% in comparison to the 20-day moving average, which settled at $0.9023. In addition, Imunon Inc saw -9.42% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IMNN starting from Braun Donald P, who purchase 25,000 shares at the price of $1.18 back on Aug 20 ’24. After this action, Braun Donald P now owns 25,597 shares of Imunon Inc, valued at $29,480 using the latest closing price.
Lindborg Stacy, the President and CEO of Imunon Inc, purchase 25,000 shares at $0.98 during a trade that took place back on Aug 15 ’24, which means that Lindborg Stacy is holding 264,166 shares at $24,500 based on the most recent closing price.
Stock Fundamentals for IMNN
Current profitability levels for the company are sitting at:
- -2.97 for the present operating margin
- 0.93 for the gross margin
The net margin for Imunon Inc stands at -689.3. The total capital return value is set at -2.34. Equity return is now at value -148.12, with -99.63 for asset returns.
Based on Imunon Inc (IMNN), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -14.38.
Currently, EBITDA for the company is -19.88 million with net debt to EBITDA at 0.45. When we switch over and look at the enterprise to sales, we see a ratio of 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.30.
Conclusion
To put it simply, Imunon Inc (IMNN) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
